Pay in 4 interest-free payments of $5.17 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
The compound's name explicitly reflects its intended indication: an anti-obesity agent designed to selectively activate the lipolytic (fat-burning) properties of growth hormone while eliminating the growth-promoting and glucose-dysregulating effects associated with intact GH
This lack of selectivity raised concerns about chronic HPA axis activation with potential adverse metabolic consequences
In both scenarios the key is consistent administration timing, tracking outcomes (sleep quality, restorative rest, stress resilience), and maintaining product/formulation integrity
The hepatic concentration of Cys-Gly, an extracellular metabolite of GSH degradation catalyzed by -glutamyl transpeptidase [36], was increased in hyperlipidemic rats compared with normal ones, indicating an increased secretion or GSH loss from the hepatocytes, followed by GSH degradation
Statements Author contributions AT: Conceptualization, Investigation, Writing original draft, Writing review and editing
US$ 23.73
US$ 27.88
US$ 29.41
US$ 22.80
